Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Bio-Rad Laboratories, Inc. Class B Common Stock stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for BIO/B.
You can purchase shares of Bio-Rad Laboratories, Inc. Class B Common Stock (NYSE:BIO/B) through any online brokerage.
Other companies in Bio-Rad Laboratories, Inc. Class B Common Stock’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), BioLife Solutions (NASDAQ:BLFS) and Waters (NYSE:WAT).
Bio-Rad Laboratories, Inc. Class B Common Stock has a consensus price target of $435.86.
The stock price for Bio-Rad Laboratories, Inc. Class B Common Stock (NYSE: BIO/B) is $311.01 last updated February 13, 2025 at 4:02 AM EST.
A quarterly cash dividend of 0.00 per share of Class A Common Stock. The quarterly cash dividend was payable on Invalid DateTime to stockholders of record on Invalid DateTime.
Bio-Rad Laboratories, Inc. Class B Common Stock’s Q1 earnings are confirmed for Tuesday, May 6, 2025.
There is no upcoming split for Bio-Rad Laboratories, Inc. Class B Common Stock.